PayPal stock (PYPL) steadies premarket after CEO shake-up and weak 2026 profit outlook
4 February 2026
2 mins read

PayPal stock (PYPL) steadies premarket after CEO shake-up and weak 2026 profit outlook

New York, Feb 4, 2026, 04:56 EST — Premarket

  • PayPal shares traded near $41.70 in premarket, following a steep 20% drop on Tuesday.
  • The board appointed HP chief Enrique Lores as CEO starting March 1; for now, CFO Jamie Miller serves as interim CEO.
  • Investors are digging into weak 2026 profit guidance alongside a cooling in PayPal’s higher-margin “branded checkout” segment.

PayPal Holdings shares hovered near $41.70 in early trading Wednesday, holding steady after tumbling sharply the day before. The stock ended Tuesday at $41.70, down 20.31%, marking its lowest point since early 2017. 1

The board appointed Enrique Lores as president and CEO, starting March 1, and named David W. Dorman as independent board chair. “Enrique is widely recognized as a visionary leader,” Dorman said. Lores added, “The payments industry is changing faster than ever.” 2

The leadership shake-up came as PayPal issued a weaker-than-anticipated profit outlook for 2026 and reported a quarterly miss. The company now expects full-year adjusted profit—a non-GAAP figure that excludes certain items—to fall anywhere from a low-single-digit percentage decline to a slight rise. This contrasts sharply with Wall Street’s roughly 8% growth forecast, based on LSEG data cited by PayPal. On the post-earnings call, interim CEO Jamie Miller told analysts, “We saw pressure across our retail merchant portfolio, particularly among lower and middle-income consumers.” 3

“Branded checkout” — the PayPal button you see on online stores — remains a key revenue driver, usually delivering higher margins than generic processing. MarketWatch flagged a slowdown in its growth, with branded-checkout climbing just 1% in Q4. In response, PayPal outlined plans to boost the checkout experience, including expanding biometric options and highlighting rewards and payment choices more clearly. Total payment volume, the amount of money processed on its platform, reached roughly $475 billion for the quarter, marking a 6% rise. 4

Analysts didn’t hold back. TD Cowen’s Bryan Bergin labeled the quarter a “broad-based miss,” highlighting transaction revenue and payment-volume numbers that fell short of Street expectations. 5

A securities filing revealed PayPal proposed a $3 million cash retention award for Miller, with 67% vesting by February 2027 and the rest in February 2028, contingent on ongoing employment. The filing also noted Alex Chriss will stay on as an employee in a non-officer capacity until March 2 to assist with the transition. 6

Lores’ offer letter details a compensation package focused largely on equity and stock performance targets. His base salary is set at $1.45 million with a target annual bonus equal to 200% of that salary. The package also includes stock awards, featuring $20 million in “make-whole” restricted stock units and a one-time $25 million grant in performance stock units tied to multi-year stock-price goals, according to a filing. 7

Competition shows no signs of letting up. The Financial Times highlighted how PayPal’s softer guidance and a CEO shakeup have heightened investor concerns over its turnaround speed. Rivals like Apple Pay and emerging buy-now, pay-later firms such as Klarna and Affirm are ramping up their efforts at checkout. 8

The risk for bulls is straightforward: a new CEO won’t suddenly boost weak consumer demand or speed up a slow merchant pipeline. If branded checkout continues to falter—or if the leadership change drags down decision-making—PayPal might see further estimate cuts and face a steeper battle for market share.

Stock Market Today

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
Meta stock ends week down about 6% as Wall Street fixates on $135 billion AI capex

Meta stock ends week down about 6% as Wall Street fixates on $135 billion AI capex

7 February 2026
Meta closed down 1.3% Friday at $661.46, capping a 6.4% weekly drop as investors questioned heavy AI spending. Amazon and Alphabet also fell after outlining major capital outlays. Meta’s Instagram suffered a brief outage this week. Legal risks persist, with trials involving Meta set for next week in Los Angeles and New Mexico.
SMCI stock steadies premarket after Super Micro lifts FY2026 sales outlook to $40 billion
Previous Story

SMCI stock steadies premarket after Super Micro lifts FY2026 sales outlook to $40 billion

Chipotle stock eyes a volatile open after flat 2026 sales outlook and menu price hike plan
Next Story

Chipotle stock eyes a volatile open after flat 2026 sales outlook and menu price hike plan

Go toTop